DENALI CAPITAL ACQ CP WTS (DNQWF) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DNQWF SEC filings page.
This page shows DENALI CAPITAL ACQ CP WTS (DNQWF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
DENALI CAPITAL ACQ CP WTS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
DENALI CAPITAL ACQ CP WTS's EBITDA was -$4.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 588.1% from the same quarter a year earlier.
DENALI CAPITAL ACQ CP WTS reported -$4.6M in net income in Q1 2026. This represents a decrease of 588.1% from the same quarter a year earlier.
Not reported for Q1 2026.
Cash & Balance Sheet
DENALI CAPITAL ACQ CP WTS held $103K in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
None of these metrics is reported for Q1 2026.
Capital Allocation
DENALI CAPITAL ACQ CP WTS invested $1.3M in research and development in Q1 2026. This represents an increase of 577.0% from the same quarter a year earlier.
Not reported for Q1 2026.
Not reported for Q1 2026.
DNQWF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24 | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $1.3M+577.0% | N/A | $1.1M+390.6% | N/A | $187K | N/A | $233K | N/A |
| SG&A Expenses | $3.3M+592.5% | N/A | N/A | N/A | $478K | N/A | $1.1M | N/A |
| Operating Income | -$4.6M-588.1% | N/A | N/A | -$375K-122.9% | -$665K-80.6% | N/A | -$1.3M-156.6% | -$168K+70.2% |
| EBITDA | -$4.6M-588.1% | N/A | N/A | N/A | -$665K | N/A | -$1.3M | N/A |
| Interest Expense | N/A | N/A | N/A | $28K+22.9% | $27K+26.6% | N/A | $25K+70.9% | $23K |
| Net Income | -$4.6M-588.1% | N/A | N/A | -$999K+10.0% | -$665K+55.8% | -$167K-126.5% | -$1.3M-305.8% | -$1.1M-342.5% |
| EPS (Basic) | -$0.02-100.0% | N/A | -$0.76-7500.0% | N/A | -$0.01 | N/A | -$0.01 | N/A |
| EPS (Diluted) | -$0.02 | N/A | -$0.76-7500.0% | N/A | -$0.01 | N/A | -$0.01 | N/A |
| Diluted Shares (Avg) | 230M | N/A | 202M+0.8% | N/A | 200M | N/A | 200M | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.
DNQWF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24 | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0M-78.5% | $1.3M-79.9% | $774K-91.3% | $562K-98.9% | $9.1M-82.2% | $6.7M-86.8% | $8.9M-90.1% | $52.1M-40.9% |
| Current Assets | $1.2M+44454.1% | $596K-90.1% | $85K+139.9% | $14K-67.7% | $3K-95.8% | $6.0M+2762.4% | $35K-0.6% | $44K-19.6% |
| Cash & Equivalents | $103K+1371.4% | $20K+66.7% | $85K+553.8% | $126-91.6% | $7K+591.0% | $12K-94.1% | $13K-3.4% | $2K-83.6% |
| Total Liabilities | $27.3M-48.1% | $22.1M-55.3% | $15.4M-69.8% | $45.0M-51.5% | $52.6M-42.2% | $49.5M-44.3% | $50.9M-48.1% | $92.8M-2.1% |
| Current Liabilities | $10.4M+32.2% | $10.2M+28951.4% | $10.0M+52.1% | $8.3M+30.9% | $7.9M+30.9% | $35K-99.4% | $6.6M+29.8% | $6.3M+68.4% |
| Non-Current Liabilities | $16.9M-62.2% | $11.9M-75.9% | $5.3M-88.0% | $36.7M-57.5% | $44.7M-47.3% | $49.4M-40.6% | $44.3M-52.3% | $86.5M-5.0% |
| Total Equity | -$25.3M+41.7% | -$20.8M+51.5% | -$14.6M+65.3% | -$44.4M-9.2% | -$43.4M-9.7% | -$42.8M-12.3% | -$42.0M-429.6% | -$40.7M-518.1% |
| Retained Earnings | -$280.4M-2511.4% | -$275.8M-139.0% | -$269.6M-2754.4% | -$11.1M-21.6% | -$10.7M-21.7% | -$115.4M-1293.1% | -$9.4M-19.1% | -$9.2M-39.1% |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Long-Term Debt.
DNQWF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24 | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.7M-569.2% | -$3.6M-156.2% | -$2.1M+30.6% | $215K+288.2% | -$399K-6.6% | -$1.4M-784.9% | -$3.0M-3858.7% | -$115K+27.4% |
| Depreciation & Amortization | $0 | N/A | $0 | N/A | $0 | N/A | $0 | N/A |
| Stock-Based Compensation | $1.5M+1513.0% | N/A | $140.2M+92131.6% | N/A | $92K | N/A | $152K | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | $0-100.0% | N/A | N/A |
| Financing Cash Flow | $2.8M+598.7% | $3.5M+151.8% | N/A | N/A | $394K+130.8% | $1.4M+103.5% | $3.2M+3899.1% | $115K-72.1% |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid.
DNQWF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$20.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where DENALI CAPITAL ACQ CP WTS Ranks
Frequently Asked Questions
What is DENALI CAPITAL ACQ CP WTS's operating cash flow?
DENALI CAPITAL ACQ CP WTS (DNQWF) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are DENALI CAPITAL ACQ CP WTS's total assets?
DENALI CAPITAL ACQ CP WTS (DNQWF) had $1.3M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does DENALI CAPITAL ACQ CP WTS spend on research and development?
DENALI CAPITAL ACQ CP WTS (DNQWF) invested $2.5M in research and development during fiscal year 2025.
What is DENALI CAPITAL ACQ CP WTS's current ratio?
DENALI CAPITAL ACQ CP WTS (DNQWF) had a current ratio of 0.06 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Why is DENALI CAPITAL ACQ CP WTS's debt-to-equity ratio negative or not reported?
DENALI CAPITAL ACQ CP WTS (DNQWF) has negative shareholder equity of -$20.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.